[en] Exercise testing has an established role in the evaluation of patients with valvular heart disease and can aid clinical decision making. Because symptoms may develop slowly and indolently in chronic valve diseases and are often not recognized by patients and their physicians, the symptomatic, blood pressure, and electrocardiographic responses to exercise can help identify patients who would benefit from early valve repair or replacement. In addition, stress echocardiography has emerged as an important component of stress testing in patients with valvular heart disease, with relevant established and potential applications. Stress echocardiography has the advantages of its wide availability, low cost, and versatility for the assessment of disease severity. The versatile applications of stress echocardiography can be tailored to the individual patient with aortic or mitral valve disease, both before and after valve replacement or repair. Hence, exercise-induced changes in valve hemodynamics, ventricular function, and pulmonary artery pressure, together with exercise capacity and symptomatic responses to exercise, provide the clinician with diagnostic and prognostic information that can contribute to subsequent clinical decisions. Nevertheless, there is a lack of convincing evidence that the results of stress echocardiography lead to clinical decisions that result in better outcomes, and therefore large-scale prospective randomized studies focusing on patient outcomes are needed in the future.
Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 48 (2006) e1-e148
Vahanian A., Baumgartner H., Bax J., et al., Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Guidelines on the management of valvular heart disease. Eur Heart J 28 (2007) 230-268
Picano E. Stress echocardiography: from pathophysiological toy to diagnostic tool. Point of view. Circulation 85 (1992) 1604-1612
Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 41 (2003) 159-168
Fox K., Garcia M.A., Ardissino D., et al., Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 27 (2006) 1341-1348
Hatazawa S., Wakahara H., Sasaki S., et al. Exercise echocardiographic evaluation of postoperative cardiac function in patients undergoing open mitral commissurotomy. Nippon Kyobu Geka Gakkai Zasshi 33 (1985) 981-988
Sagar K.B., Wann L.S., Paulson W.J., and Lewis S. Role of exercise Doppler echocardiography in isolated mitral stenosis. Chest 92 (1987) 27-30
Pellikka P.A., Nagueh S.F., Elhendy A.A., Kuehl C.A., and Sawada S.G. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20 (2007) 1021-1041
Sicari R., Niohyannopoulos P., Evangelista A., et al. Stress echocardiography consensus statement of the European Association of Echocardiography. Eur J Echocardiogr 9 (2008) 415-437
Clyne C.A., Arrighi J.A., Maron B.J., Dilsizian V., Bonow R.O., and Cannon III R.O. Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis. Am J Cardiol 68 (1991) 1469-1476
Otto C.M., Pearlman A.S., Kraft C.D., Miyake-Hull C.Y., Burwash I.G., and Gardner C.J. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J Am Coll Cardiol 20 (1992) 1160-1167
Otto C.M., Burwash I.G., Legget M.E., et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 95 (1997) 2262-2270
Amato M.C., Moffa P.J., Werner K.E., et al. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 86 (2001) 381-386
Alborino D., Hoffmann J.L., Fournet P.C., et al. Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. J Heart Valve Dis 11 (2002) 204-209
Das P., Rimington H., and Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 26 (2005) 1309-1313
Otto C.M., Pearlman A.S., Kraft C.D., Miyake-Hull C.Y., Burwash I.G., and Gardner C.J. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J Am Coll Cardiol 20 (1992) 1160-1167
Lancellotti P., Lebois F., Simon M., Tombeux C., Chauvel C., and Pierard L.A. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 112 Suppl I (2005) I377-I382
Leurent G., Donal E., de Place C., et al. Argument for a Doppler echocardiography during exercise in assessing asymptomatic patients with severe aortic stenosis. Eur J Echocardiogr 10 (2009) 69-73
Lancellotti P., Karsera D., Tumminello G., Lebois F., and Piérard L.A. Determinants of an abnormal response to exercise in patients with asymptomatic valvular aortic stenosis. Eur J Echocardiogr 9 (2008) 338-343
Maréchaux S., Ennezat P.V., LeJemtel T.H., et al. Left ventricular response to exercise in aortic stenosis: an exercise echocardiographic study. Echocardiography 24 (2007) 955-959
Grayburn P.A. Assessment of low-gradient aortic stenosis with dobutamine. Circulation 113 (2006) 604-606
deFilippi C.R., Willett D.L., Brickner M.E., et al. Usefulness of dobutamine echocardiography in distinguishing severe from non severe valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75 (1995) 191-194
Schwammenthal E., Vered Z., Moshkowitz Y., et al. Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction: predicting outcome as a function of management strategy. Chest 119 (2001) 1766-1777
Nishimura R.A., Grantham J.A., Connolly H.M., Schaff H.V., Higano S.T., and Holmes Jr. D.R. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106 (2002) 809-813
Monin J.L., Monchi M., Gest V., Duval-Moulin A.M., Dubois-Rande J.L., and Gueret P. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low dose dobutamine echocardiography. J Am Coll Cardiol 37 (2001) 2101-2107
Monin J.L., Quere J.P., Monchi M., et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108 (2003) 319-324
Quere J.P., Monin J.L., Levy F., et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 113 (2006) 1738-1744
Picano E., Mathias Jr. W., Pingitore A., Bigi R., Previtali M., and EDIC Study Group. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large-scale, multicenter trial. Lancet 344 (1994) 1190-1192
Bountioukos M., Kertai M.D., Schinkel A.F., et al. Safety of dobutamine stress echocardiography in patients with aortic stenosis. J Heart Valve Dis 12 (2003) 441-446
Blais C., Burwash I.G., Mundigler G., et al. The projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low flow aortic stenosis: the multicenter TOPAS (Truly or Pseudo Severe Aortic Stenosis) study. Circulation 113 (2006) 711-721
Tribouilloy C., Levy F., Rusinaru D., et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 53 (2009) 1865-1873
Rahimtoola S.H. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72 (1985) V123-V135
Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
Marwick T.H. Application of stress echocardiography to the evaluation of non-coronary heart disease. Eur J Echocardiogr 1 (2000) 171-179
Picano E., Pálinkás A., and Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 19 (2001) 1177-1183
Dujardin K.S., Enriquez-Sarano M., Schaff H.V., Bailey K.R., Seward J.B., and Tajik A.J. Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation 99 (1999) 1851-1857
Klodas E., Enriquez-Sarano M., Tajik A.J., et al. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol 30 (1997) 746-752
Bonow R.O., Dodd J.T., Maron B.J., et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation 78 (1988) 1108-1120
Wahi S., Haluska B., Pasquet A., Case C., Rimmermann C.M., and Marwick T.H. Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asymptomatic severe aortic regurgitation. Heart 84 (2000) 606-614
Espinola-Zavaleta N., Gómez-Núñez N., Chávez P.Y., et al. Evaluation of the response to pharmacological stress in chronic aortic regurgitation. Echocardiogr 18 (2001) 491-496
Bonow R.O., Lakatos E., Maron B.J., and Epstein S.E. Serial long term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 84 (1991) 1625-1635
Tornos M.P., Olona M., Permanyer-Miralda G., et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study. Am Heart J 130 (1995) 333-339
Borer J.S., Hochreiter C., Herrold E.M., et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 97 (1998) 525-534
Tamas E., Broqvist M., Olsson E., Franzen S., and Nylander E. Exercise radionuclide ventriculography for predicting post-operative left ventricular function in chronic aortic regurgitation. J Am Coll Cardiol Img 2 (2009) 48-55
Schwammenthal E., Vered Z., Agranat O., Kaplinsky E., Rabinowitz B., and Feinberg M.S. Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation 102 (2000) 2378-2384
Reis G., Motta M.S., Barbosa M.M., Esteves W.A., Souza S.F., and Bocchi E.A. Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis. J Am Coll Cardiol 43 (2004) 393-401
Li M., Dumesnil J.G., Mathieu P., et al. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 45 (2005) 1034-1040
Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
Enriquez-Sarano M., Avierinos J.F., Messika-Zeitoun D., et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352 (2005) 875-883
Rosenhek R., Rader F., Klaar U., et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113 (2006) 2238-2244
Madaric J., Watripont P., Bartunek J., et al. Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation. Am Heart J 154 (2007) 180-185
Kang D.H., Kim J.H., Rim J.H., et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 119 (2009) 797-804
Supino P.G., Borer J.S., Schuleri K., et al. Prognostic value of exercise tolerance testing in asymptomatic chronic nonischemic mitral regurgitation. Am J Cardiol 100 (2007) 1274-1281
Tischler M.D., Battle R.W., Saha M., Niggel J., and LeWinter M.M. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J Am Coll Cardiol 25 (1995) 128-133
Lee R., Haluska B., Leung D.Y., Case C., Mundy J., and Marwick T.H. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 91 (2005) 1407-1412
Lancellotti P., Cosyns B., Zacharakis D., et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr 21 (2008) 1331-1336
Grigioni F., Enriquez-Sarano M., Zehr K.L., Bailey K.R., and Tajik A.J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001) 1759-1764
Robbins J.D., Maniar P.B., Cotts W., Parker M.A., Bonow R.O., and Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 91 (2003) 360-362
Koelling T.M., Aaronson K.D., Cody R.J., Bach D.S., and Armstrong W.F. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144 (2002) 524-529
Bursi F., Enriquez-Sarano M., Nkomo V.T., et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111 (2005) 295-301
Yiu S.F., Enriquez-Sarano M., Tribouilloy C., Seward J.B., and Tajik A.J. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 102 (2000) 1400-1406
Kwan J., Shiota T., Agler D.A., et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 107 (2003) 1135-1140
Levine R.A., and Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 112 (2005) 745-758
Rizzello V., Poldermans D., Boersman E., et al. Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 110 (2004) 2383-2388
Capomolla S., Febo O., Gnemmi M., et al. β-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 139 (2000) 596-608
St John Sutton M.G., Plappert T., Abraham W.T., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
Bax J.J., Abraham T., Barold S.S., et al. Cardiac resynchronization therapy. Part 2-issues during and after device implantation and unresolved questions. J Am Coll Cardiol 46 (2005) 2168-2182
Cleland J.G.F., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
Prifti E., Bonacchi M., Frati G., Giunti G., Babatasi G., and Sani G. Ischemic mitral valve regurgitation grade II-III: correction in patients with impaired left ventricular function undergoing simultaneous coronary revascularization. J Heart Valve Dis 10 (2001) 754-762
Bax J.J., Braun J., Somer S.T., et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 110 Suppl II (2004) II103-II108
Sicari R., Picano E., Cortigiani L., et al. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 92 (2003) 1263-1266
Schinkel A.F.L., Bax J.J., Poldermans D., Elhendy A., Ferrari R., and Rahimtoola S.H. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32 (2007) 375-410
Camici P.G., Prasad S.K., and Rimoldi O.E. Stunning, hibernation, and assessment of myocardial viability. Circulation 117 (2008) 103-114
Seghatol F.F., Shah D.J., DiLuzio S., et al. Relation between contractile reserve and improvement in left ventricular function with beta blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 93 (2004) 854-859
Ypenburg C., Sieders A., Bleeker G.B., et al. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Am Heart J 154 (2007) 1160-1165
McGee E.C., Gillinov A.M., Blackstone E.H., et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128 (2004) 916-924
Wu A.H., Aaronson K.D., Bolling S.F., Pigani F.D., Welxh K., and Koelling T.M. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45 (2005) 381-387
Mihaljevic T., Lam B.K., Rajeswaran J., et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 49 (2007) 2191-2201
Lancellotti P., Lebrun F., and Piérard L.A. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 42 (2003) 1921-1928
Lancellotti P., Troisfontaines P., Toussaint A.C., and Pierard L.A. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 108 (2003) 1713-1717
Pierard L.A., and Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351 (2004) 1627-1634
Lancellotti P., Gérard P., and Piérard L.A. Long term outcome of patients with heart failure and dynamic mitral regurgitation. Eur Heart J 26 (2005) 1528-1532
Pierard L.A., and Lancellotti P. Stress testing in valve disease. Heart 93 (2007) 766-772
Lancellotti P., Donal E., Cosyns B., et al. Effects of surgery on ischaemic mitral regurgitation: a prospective multicentre registry (SIMRAM registry). Eur J Echocardiogr 9 (2008) 26-30
Rahimtoola S.H. The problem of valve prosthesis-patient mismatch. Circulation 58 (1978) 20-24
Pibarot P., and Dumesnil J.G. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve and its prevention. J Am Coll Cardiol 36 (2000) 1131-1141
Rahimtoola S.H., and Murphy E. Valve prosthesis-patient mismatch: a long-term sequela. Br Heart J 45 (1981) 331-335
Blais C., Dumesnil J.G., Baillot R., Simard S., Doyle D., and Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 108 (2003) 983-988
Ruel M., Rubens F.D., Masters R.G., et al. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves. J Thorac Cardiovasc Surg 127 (2004) 149-159
Mohty D., Malouf J.F., Girard S.E., et al. Impact of prosthesis-patient mismatch on long-term survival in patients with small St. Jude medical mechanical prostheses in the aortic position. Circulation 113 (2006) 420-426
Magne J., Mathieu P., Dumesnil J.G., et al. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation 115 (2007) 1417-1425
Bleiziffer S., Eichinger W.B., Hettich I., et al. Impact of prosthesis-patient mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement. Heart 94 (2008) 637-641
Pibarot P., and Dumesnil J.G. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 119 (2009) 1034-1048
Pibarot P., Dumesnil J.G., Jobin J., et al. Hemodynamic and physical performance during maximal exercise in patients with an aortic bioprosthetic valve: comparison of stentless versus stented bioprostheses. J Am Coll Cardiol 34 (1999) 1609-1617
Pibarot P., Dumesnil J.G., Jobin J., et al. Usefulness of the indexed effective orifice area at rest in predicting an increase in gradient during maximum exercise in patients with a bioprosthesis in the aortic valve position. Am J Cardiol 83 (1999) 542-546
Tatineni S., Barner H.B., Pearson A.C., et al. Rest and exercise evaluation of St. Jude Medical and Medtronic Hall prostheses: influence of primary lesion, valvular type, valvular size, and left ventricular function. Circulation 80 Suppl I (1989) I16-I23
Hobson N.A., Wilkinson G.A., Cooper G.H., Wheeldon N.M., and Lynch J. Hemodynamic assessment of mitral mechanical prostheses under high flow conditions: comparison between dynamic exercise and dobutamine stress. J Heart Valve Dis 15 (2006) 87-91
Tricoci P., Allen J.M., Kramer J.M., Califf R.M., and Smith Jr. S.C. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301 (2009) 831-841
